Zivo Bioscience Inc   (ZIVO)
Other Ticker:  
Price: $9.5000 $0.25 2.703%
Day's High: $9.95 Week Perf: 18.75 %
Day's Low: $ 9.00 30 Day Perf: 42.91 %
Volume (M): 1 52 Wk High: $ 13.00
Volume (M$): $ 13 52 Wk Avg: $2.77
Open: $9.00 52 Wk Low: $0.48

 Market Capitalization (Millions $) 16
 Shares Outstanding (Millions) 2
 Employees 2
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -9
 Cash Flow (TTM) (Millions $) -2
 Capital Exp. (TTM) (Millions $) 0

Zivo Bioscience Inc
We were incorporated under the laws of the State of Nevada on March 28, 1983, under the name of “L. Peck Enterprises, Inc.” On May 27, 1999, we changed our name to “Western Glory Hole, Inc.” From 1990 until October 2003, we had no business operations; we were in the development stage and were seeking profitable business opportunities. On October 30, 2003, we acquired 100% of the outstanding shares of Health Enhancement Corporation (“HEC”) in exchange for 9,000,000 of our shares, making HEC our wholly-owned subsidiary. In connection with this transaction, we changed our name to Health Enhancement Products, Inc. On October 14, 2014, at the annual meeting of the Shareholders of the Company, a proposal was passed to change the name of the Company from Health Enhancement Products, Inc. to Zivo Bioscience, Inc. (“ZIVO”). On October 30, 2014, the Financial Industry Regulatory Authority (“FINRA”) approved the name Zivo Bioscience, Inc. for trading purposes and the symbol change to ZIVO effective November 10, 2014.

   Company Address: 21 E. Long Lake Road Bloomfield Hills 48304 MI
   Company Phone Number: 452 9866   Stock Exchange / Ticker: NASDAQ ZIVO
   ZIVO is expected to report next financial results on March 13, 2024.

Customers Net Income fell by ZIVO's Customers Net Profit Margin fell to

-83.03 %

0.52 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


Stock Performances by Major Competitors

5 Days Decrease / Increase
ABT        4.78% 
BMY        3.61% 
CAG        4.01% 
DD        2.21% 
JNJ        3.38% 
PFE        0.51% 
• View Complete Report

Zivo Bioscience Inc

Zivo Bioscience Inc Demonstrates Positive Revenue Growth in Q3 2023

Investors in the stock market have always sought opportunities that have the potential to provide significant returns. In a constantly evolving market, it is important to identify hidden gems that offer the promise of success. One such company that has caught the attention of investors is Zivo Bioscience Inc.
In the third quarter of 2023, Zivo Bioscience Inc reported an impressive revenue of $0.0118 million. This indicates the company's ability to generate consistent income, which is a positive sign for investors. Furthermore, Zivo Bioscience Inc managed to reduce its net loss to $-1.825 million, compared to a deficit of $-2.004 million in the same reporting period the previous year. This reflects the company's efforts to improve its financial performance and move towards profitability.

Stock Split

Zivo Bioscience Undertakes Reverse Stock Split, Offers Potential Road to Recovery for Shareholders

Published Thu, Oct 26 2023 12:30 PM UTC

In a recent press release, Zivo Bioscience, a prominent biotech/agtech R&D company specializing in the development of therapeutic, medicinal, and nutritional products derived from proprietary algal cultures, announced its approval of a 1-for-6 reverse stock split. The split, effective at 5:00 p.m. ET on October 26, 2023, aims to potentially alleviate the struggles faced...

Zivo Bioscience Inc

Zivo Bioscience Inc Posts Impressive Revenue of $0.00405 Million, Despite Net Losses, Expectations High for November Earnings Report

Zivo Bioscience Inc, a leading Biotechnology & Pharmaceuticals company, has recently released its financial report for the period ending June 30, 2023. During this time, the company reported a revenue of $0.00405 million. However, the company faced a net loss of $-2.071 million, which is slightly improved when compared to the deficit of $-2.072 million during the same reporting season a year ago. The next financial earnings report from Zivo Bioscience Inc is expected to be published on November 13, 2023.
In terms of market performance, Zivo Bioscience Inc shares have experienced a decline of -2.9% in the past 7 days. This has further contributed to the year-to-date performance which currently stands at -19.28%. Despite this decline, the company's shares are currently trading 15.5% above its 52-week low.


Zivo Bioscience Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com